Key facts
- SMi Systems’s last known valuation is $52.6M (Dec 2025).
- It has raised $9.5M; the latest was Later Stage VC ($6.6M) in Dec 2025.
- Notable investors include Innovate UK, Norcliffe Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for SMi Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for SMi Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SMi Systems
Developer of single-molecule discovery and diagnostic tools intended for biomedical research and clinical diagnostics. The company's automated high-throughput platform uses super-resolution microscopy and data analysis software for multi-omic (DNA, RNA, and protein) and multiplexed molecular detection and quantification, enabling researchers and drug developers to analyze molecular interactions and assess drug-target binding.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2018
- Employees
- 19
- Website
- smisystems.co.uk/
- Ownership
- Privately Held (backing)
SMi Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SMi Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SMi Systems in its N-PORT filings yet. We sweep new filings monthly.